Martin Shkreli-Linked KaloBios Emerges From Bankruptcy, Vows Better Drug Pricing
July 05, 2016 at 01:29 AM EDT
KaloBios Pharmaceuticals said Friday it has emerged from Chapter 11 bankruptcy and has also acquired the rights from Savant Neglected Diseases LLC to develop benznidazole for the treatment of Chagas disease.